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Here, we assess the role of this transcription factor in  morphine-
induced behaviors and striatal function using a new strain of 
bitransgenic mice that express A-CREB, a dominant and strong 
inhibitor of the CREB family of transcription factors in striatal neu-
rons in a regulatable and highly restricted manner. Our experiments 
confi rm previous fi ndings and support a role for CREB-dependent 
gene expression in GABAergic striatal neurons regulating approach/
avoidance behaviors toward cues associated to appetitive/aversive 
consequences derived from chronic drug exposure.
MATERIALS AND METHODS
GENERATION AND MAINTENANCE OF TRANSGENIC MICE
Several lines of transgenic mice expressing A-CREB under the 
control of tetO promoter were generated by microinjection 
and backcrossed to C57BL/6J. We have previously described in 
detail (Jancic et al., 2009) the bitransgenic mice resulting of the 
crossing of pCaMKII-tTA mice line B (Mayford et al., 1996) and 
tetO-A-CREB line AC95 (ACREB-FB in Figure 1A), which showed 
the highest level of expression in the hippocampus among the 
different founder obtained by microinjection. In this study, we 
investigated the phenotype of bitransgenic animals that resulted 
of the crossing of pCaMKII-tTA mice line B and tetO-A-CREB 
line AC100, which express the transgene exclusively in the stria-
tum. We refer to this bitransgenic strain as ACREB-St mice. In 
all our experiments, we used as control littermate mice carrying 
either pCaMKII-tTA, tetO-A-CREB or none transgene. For reversal 
experiments,  doxycycline (dox) was administrated at 40 mg/kg 
of food and added at the indicated times. Experiments were per-
formed in adult male mice (2- to 4-month-old). All mice were 
INTRODUCTION
In their attempt to adapt to the environment and survive, indi-
viduals rapidly learn to approach or avoid biologically relevant 
stimuli as well as the cues and contexts that predict their appear-
ance (Domjan, 2005). As subserving learning, that is, changes in 
perception, interpretation and response to relevant stimuli, neural 
plasticity is a main determinant of animal’s behaviors and of their 
adaptive capabilities. Through its regulatory role on gene expres-
sion, transcription factors are key elements of neural plasticity and 
its consequences on behavior (McClung and Nestler, 2008).
The cAMP responsive element (CRE)-binding protein, CREB, is a 
constitutively expressed transcription factor that becomes activated 
by phosphorylation through several signaling cascades and repre-
sents a convergence point through which incoming information 
from several intracellular pathways can be integrated and trans-
lated in different patterns of gene expression (Mayr and Montminy, 
2001). Accordingly, CREB has been associated with neuroplasticity 
processes underlying different forms of learning and memory and 
several psychiatric disorders, including the cellular and molecu-
lar changes induced by drugs of abuse (Carlezon et al., 2005). In 
this regard, it has been shown that psychostimulants and opiates 
increase CREB phosphorylation and CRE-mediated gene expression 
in specifi c neuronal populations (Konradi et al., 1994; Hyman et al., 
1995; Shaw-Lutchman et al., 2003; Walters et al., 2003; Carlezon 
et al., 2005; Olson et al., 2005). The behavioral signifi cance of these 
molecular adaptations is complex and seems to differ notably among 
different brain areas (Carlezon et al., 2005). Indeed, CREB-related 
neuroplasticity has been previously related to drug reinforcement, 
tolerance, and withdrawal (Nestler, 2004; Carlezon et al., 2005).
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maintained and bred under standard conditions, consistent with 
national guidelines and approved by the Institutional Animal Care 
and Use Committees.
DRUGS
Morphine sulfate and naloxone hydrochloride were purchased from 
Sigma Aldrich Química S. A. (Madrid, Spain). Drugs were dissolved 
in a saline (0.9% w/v) solution and injected intraperitoneally (i.p.). 
The same volume of vehicle was administered to control groups.
BASAL BEHAVIOR
An initial behavioral characterization was performed in a sepa-
rate cohort of ACREB-St (N = 9) and control (N = 7) littermate 
mice. Open fi eld locomotion: Mice locomotion in the open fi eld 
was measured in a single testing session (duration: 20 min) con-
ducted in a room softly illuminated. The open-fi eld chamber 
 consisted of a clear glass cylinder 25 cm in diameter and 30 cm 
high. Locomotor activity was registered by a computerized video 
tracking system (SMART, Panlab S.L; Barcelona, Spain) and calcu-
lated as travelled distance (centimeter). Novel cage test: Reactivity to 
a novel environment was tested by assessing the number of rearing 
episodes in a single exposure (duration: 5 min) to a new envi-
ronment. The new environment was a standard type II macrolon 
cage with a thin layer of bedding material (Sanchis-Segura et al., 
2006). Anxiety-like behavior: Anxiety-like behavior was measured 
by means of two well-standardized tests: The elevated plus maze 
and the dark-light box.
MORPHINE RELATED BEHAVIORS
Morphine-induced conditioned place preference (CPP): CPP was 
assessed using four black acrylic chambers (30 cm × 15 cm × 20 cm) 
contained in a dimly-illuminated and sound attenuated enclosure. 
No divider was used in the chambers so animals had access to 
the entire box. Tactile cues (interchangeable grid and hole fl oors) 
were used as conditioned stimuli (CS). The behavioral procedure 
had three phases: (1) A habituation session was implemented by 
placing each animal in the CPP chambers (fl oor divided with 
half grid, half holes) for 15 min. (2) Mice were examined in eight 
trials (60-min duration; one trial per day), corresponding to four 
morphine/CS+ pairings and four saline/CS− pairings. The use 
of both fl oor types as CS+ or CS− was counterbalanced among 
groups using an unbiased CPP design. Morphine (20 mg/kg) or 
saline was administered immediately before placing the mice into 
the conditioning chambers prepared with the corresponding CS+ 
or CS− fl oor. CS+ and CS− pairing sessions were alternated fol-
lowing an ABABAB sequence with all animals receiving fi rst a 
CS+ session. (3) A single preference test (duration: 15 min) was 
conducted the day after the last conditioning session. In this case 
the fl oor of the conditioning chambers was divided (half grid, 
half holes) and the time spent in each fl oor was assessed by a 
video-tracking system (SMART, Panlab S.L; Barcelona, Spain). 
As described in the statistics section, the percent of time spent 
in the CS+ compartment was the preference index used in this 
experiment. Opioid dependence induction: Opioid dependence was 
induced by repeated injections of morphine based on the proce-
dure described by (Maldonado et al., 1996). Mice received mor-
phine injections twice a day (9 AM and 9 PM) with progressively 
increasing doses (20, 40, 60, 80, and 100 mg/kg, i.p.) in their home 
cages for fi ve consecutive days. On the 6th day, mice were treated 
with a single morphine (100 mg/kg, i.p.; 9 AM) injection. Separate 
groups of mice exposed to this dependence-induction drug sched-
ule were used for assessing morphine withdrawal signs or mor-
phine withdrawal-induced conditioned place avoidance (CPA). 
Expression of morphine withdrawal signs: Morphine dependence 
was induced by the procedure described above. Ninety minutes 
after the last morphine injection (day 6), mice were individu-
ally placed in cubic metacrylate boxes (40 cm × 40 cm × 40 cm). 
Fifteen minutes later, morphine withdrawal was precipitated by 
a subcutaneous naloxone injection (0.1 mg/kg) and mice behav-
ior was videotaped for additional 15 min. Several signs of the 
morphine withdrawal syndrome were evaluated by an observer 
blind to genotype. Morphine withdrawal global score was cal-
culated using the relative weight values for behavioral signs 
previously described in Maldonado et al. (1996); a weight value 
of 0.5 was used for those signs that were not included in that 
study. Morphine withdrawal-induced CPA: Morphine-induced 
CPA was evaluated in the same four black acrylic conditioning 
boxes previously described using interchangeable grid and hole 
fl oors as CS. Half of the subjects of each genotype/treatment 
group experienced morphine-withdrawal (see below) in each of 
these alternative fl oors (CS+). The conditioning was achieved 
in a single conditioning session. Thus, after receiving the drug 
regime previously described, 2 h after the last morphine injec-
tion (day 6), morphine- dependent mice received a subcutaneous 
naloxone challenge (0.1 mg/kg). Immediately after this treatment, 
mice were placed for 15 min in a conditioning box equipped with 
one of the fl oors, arbitrarily assigned as CS+. Twenty-four hours 
after this conditioning session, the possible development of CPA 
was evaluated by a single preference test (duration: 15 min). In 
this case the fl oor of each conditioning chamber was divided 
(half grid, half holes) and the time spent by each mouse in each 
type of fl oor was assessed by a video-tracking system (SMART, 
Panlab S.L; Barcelona, Spain). Similarly to the CPP experiment 
previously described, the percent of time spent in the CS+ was 
used as the index of the conditioned avoidance.
OTHER TECHNIQUES
Nissl staining, in situ hybridization and immunostaining were per-
formed as previously described (Lopez de Armentia et al., 2007; 
Jancic et al., 2009). Anti Flag-M2 (F1804, mouse monoclonal) and 
anti-DARPP-32 (ab40801, rabbit monoclonal) antibodies were 
obtained from Abcam (Cambridge, UK).
STATISTICS
Data were normalized by squared root transformation in all cases 
to ensure a normal distribution and allow the use of percentages in 
parametric statistics. The different indexes of the general behavioral 
characterization conducted in ACREB-St and their corresponding 
littermate controls were analyzed by a multiple analysis of variance 
(MANOVA) using the genotype as between groups factor. CPP 
and CPA were analyzed by means of separate two-way ANOVA 
(genotype × treatment) using as dependent variable the percent 
of time in the CS+. For clarity, CPA data are displayed as an arith-
metic transformation of this variable (% time spent in CS+ minus 
Frontiers in Behavioral Neuroscience www.frontiersin.org September 2009 | Volume 3 | Article 30 | 3
Sanchis-Segura et al. CREB control of approach/avoidance responses
100%). Morphine withdrawal was analyzed by means of MANOVA 
using the genotype as a between-groups factor. The Chi-squared 
test was used to compare the proportion of mice exhibiting ptosis 
or piloerection in each group at any moment of the morphine 
withdrawal test.
RESULTS
REGULATED AND HIGHLY RESTRICTED EXPRESSION OF A-CREB 
IN STRIATUM
To investigate the consequences of impaired CREB-dependent 
gene expression in striatal neurons, we generated transgenic mice 
expressing the repressor of CRE-binding activity A-CREB using 
the CamKIIα-tTA/tetO system of inducible double transgenics 
(Mayford et al., 1996). One of these bitransgenic strains (result-
ing of crossing tetO-A-CREB line AC100) showed expression of 
A-CREB transcripts exclusively in striatal neurons (Figures 1A-C), 
for this reason, we will refer to it as ACREB-St mice. This strain 
might be especially appropriate to investigate the role of CREB-
dependent gene expression in striatal-related function and behavior. 
Histological examination of brain sections did not reveal any gross 
abnormality in ACREB-St mice (Figure 2A), whereas immunohisto-
logical analyses revealed the expression of this inhibitory peptide in 
neurons of both the dorsal hippocampus and the nucleus accumbens 
(NA, Figure 2B,C). Double immunostaining with  antibodies against 
Flag-M2, which recognizes A-CREB, and DARPP-32, the most com-
monly used marker for medium spiny neurons, demonstrated that 
100% of the neurons expressing the transgene belong to this neu-
ronal type (Figure 3).
FIGURE 1 | Bitransgenic mice with inducible and highly restricted 
expression of A-CREB in striatal neurons. (A) Comparison of the pattern 
of transgene expression in brain sagittal sections from a bitransgenic 
ACREB-St mouse, a control littermate, and a bitransgenic ACREB-FB mouse 
(the strain characterized in detail in Jancic et al., 2009) visualized by in situ 
hybridization using an oligonucleotide probe specifi c for the A-CREB 
transgene. (B,C) DIG in situ hybridization showing transgene expression in 
the striatum (C), but not in the hippocampus (B) of a 5-months old ACREB-St 
mouse using a probe specifi c for A-CREB transgene. The white arrows label 
positive striatal cells. The same pattern of expression was observed in three 
mice per genotype.
FIGURE 2 | Normal gross brain anatomy in ACREB-St mice. (A) Nissl 
staining of the coronal brain section of an adult ACREB-St mouse and a control 
littermate did not reveal gross anatomical changes (scale bar: 1 mm). (B) 
Immunostaining of brain sections showed Flag-M2 immunoreactivity in the 
dorsal striatum of ACREB-St mice (right), but not in their control littermates 
(left). Hippocampus, cortical layers and other brain regions did not show 
immunoreactivity (scale bar: 1 mm). (C) Immunostaining of coronal brain 
sections in an ACREB-St mouse showed positive cells (white arrows) both in 
the dorsal striatum (upper inset) and in the nucleus accumbens (lower inset). 
Scale bar: 0.5 mm. The same pattern of expression was observed in three 
mice per genotype.
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GENERAL BEHAVIORAL CHARACTERIZATION
Although a MANOVA comparing both strains of mice yielded 
a genotype effect (Wilk’s lambda 7, 8 = 0.125, p < 0.01), follow 
up ANOVA-based univariate comparisons revealed that with the 
exception of a slight decrease of body weight (p < 0.01), ACREB-St 
mice did not display any major morphologic or developmental 
alteration. Similarly, at the behavioral level, ACREB-St mice did 
not exhibit major alterations regarding spontaneous locomotion, 
novelty reactivity or anxiety-like behavior. Thus, ACREB-St mice 
and their control littermates did not differ in the distance traveled 
in the open fi eld or the number of rearing episodes in the novel 
cage test. Also, both genotypes spent similar amounts of time in the 
open arms of the plus maze and in the light compartment of the 
light-dark box, although in these tests ACREB-St mice displayed a 
reduction in the total number of arms entries and compartment 
visits (p < 0.01 in all cases). These results are shown in Table 1.
MORPHINE-INDUCED CONDITIONED PLACE PREFERENCE
Regardless their genotype or the diet they received, mice did not 
display innate preference for any of the compartments of the con-
ditioning box during the habituation session (F
1,30
 = 0.42, N.S.), 
whereas repeated pairings of morphine to a specifi c environment 
resulted in an increase of preference for that environment during 
a test conducted at later times, a behavior referred as conditioned 
place preference or CPP (see scheme in Figure 4A). As shown in 
Figure 4B, the strength of the CPP test carried out 24 h after the 
last pairing differed among genotypes in mice in which transgene 
expression was turned on (Figure 4B: Off Dox). The addition of 
dox to the mouse diet can repress transgene expression in less than 
1 week (Jancic et al., 2009). Notably, dox treatment abolished the 
differences between genotypes in the CPP task (Figure 4B: On Dox). 
Thus, a two-way ANOVA (genotype × treatment) revealed a sig-
nifi cant interaction between both factors (F
1,33
 = 4.39, p < 0.05) and 
post hoc comparisons showed that dox-untreated ACREB-St mice 
signifi cantly differed of the rest of the experimental groups (p < 0.05 
in all cases), demonstrating the reversal of the CPP phenotype.
FIGURE 3 | Expression of A-CREB protein and colocalization with a marker 
for interneurons. Double immunostaining using antibodies against Flag-M2, 
which recognizes A-CREB, and DARPP-32. The colocalization of both markers 
demonstrates that the transgene is expressed in striatal GABAergic medium 
spiny neurons (MSNs). The right panels show the overlay of Flag-M2 (in red) and 
DARPP-32 (in green) staining, and DAPI (in blue) counterstaining. The white 
arrows label positive MSNs for Flag-M2 and DARPP-32 (in yellow). Scale bar: 
50 µm. The same result was observed in three mice per genotype.
Table 1 | General characterization of ACREB-St mice.
 Control ACREB-St
Body weight 31.5 ± 0.72 25.3 ± 0.8*
Locomotion (cm/20 min) 3517.4 ± 289.5 3721.2 ± 362.7
Novelty reaction (rearing  34.2 ± 4.1 39. 2 ± 3.9
episodes in 5 min)  
PLUS MAZE
Time spent in the open  29.85 ± 10.66 40.28 ± 12.93
arms (s)  
Total number of entries 13.71 ± 1.58 6.78 ± 0.85*
DARK-LIGHT BOX
Time spent in the light  91.53 ± 21.38 57.08 ± 7.42
compartment (s)  
Total number of  9.71 ± 0.52 6.22 ± 0.91*
compartment changes  
Body weight and performance in several basal behavioral tests were assessed 
in a cohort of nine ACREB-St mice and seven control littermates. Data are 
presented as mean ± SEM. (*) Indicates p < 0.01.
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MORPHINE WITHDRAWAL
The severity of morphine withdrawal did not substantially differ 
between ACREB-St mice and their control littermates (Table 2). 
A MANOVA comparing the frequency of different morphine 
 withdrawal signs, such as forepaw tremor, shakes, chewing, jumping 
grooming, rearing and digging, did not yield a signifi cant difference 
between genotypes (Wilk’s lambda
7,8
 = 0.303, p = 0.10). Specifi c 
comparisons conducted by independent one-way ANOVAs mainly 
confi rmed this overall result, although also revealed a reduced 
number of rearing (p < 0.01) and digging (p < 0.05) episodes in 
ACREB-St mice. Further, the proportion of mice exhibiting ptosis 
or piloerection did not differ between genotypes when compared 
by means of the chi-squared test (p = 0.61 and 0.95, respectively). 
Similar conclusions, that is, the lack of differences between geno-
types in the intensity of morphine withdrawal were drawn using a 
global withdrawal score (t
14
 = 1.16, p = 0.26).
MORPHINE WITHDRAWAL–INDUCED CONDITIONED PLACE AVOIDANCE
Regardless of their genotype or the presence of dox in the diet, 
mice did not display any innate preference for any of the com-
partments of the conditioning box during the habituation session 
(F
1,30
 = 0.42, N.S.). However, pairing morphine withdrawal with an 
environment resulted in the avoidance of this environment dur-
ing a test conducted 24 h later (CPA, see scheme in Figure 5A). 
The magnitude of this effect markedly differed among the dif-
ferent treatment groups. Thus, as revealed by a two-way ANOVA 
(genotype × diet), both main factors (F
1,30
 = 29.15, p < 0.01 and FIGURE 4 | Conditioned place preference. (A) Schematic representation of 
the behavioral training protocol and treatment groups used in the conditioned 
place preference (CPP) experiment. Although for clarity the scheme presents 
the “holes” fl oor as CS+, this factor was counterbalanced across genotypes 
and dox treatment (see Section “Materials and Methods” for further details). 
(B) CPP was evaluated as the percent of time spent in the environment paired 
to morphine (20 mg/kg) administration during a preference test conducted 
24 h after the last conditioning session. Black and white bars depict the results 
for ACREB-St and littermate control mice, respectively. The horizontal dotted 
line indicates the indifference (e.g., 50%) point. *p < 0.05 as compared to all 
other groups.
Table 2 | Morphine withdrawal signs in ACREB-St mice and control 
littermates.
 Control (N = 7) ACREB-St (N = 9)
Forepaw tremor 11.00 ± 2.39 8.11 ± 1.34
Shakes 3.43 ± 0.68 4.00 ± 0.74
Chewing 5.43 ± 0.92 4.44 ± 0.60
Jumping 21.57 ± 3.51 26.33 ± 2.76
Grooming 12.43 ± 2.74 12.88 ± 2.45
Rearing 19.43 ± 2.75 10.22 ± 1.07*
Digging 10. 14 ± 2.72 3.89 ± 0.65*
Ptosis 4/7 5/9
Piloerection 5/7 5/9
Global withdrawal score 59.30 ± 2.48 52.96 ± 4.36
Morphine-dependent mice were challenged with a single naloxone (0.1 mg/kg; 
IP) injection and the frequency of different signs of morphine withdrawal was 
measured. Data are expressed as mean ± SEM, with the exception of ptosis and 
piloerection which are expressed as the proportion of subjects exhibiting those 
signs in each genotype. (*) indicates p < 0.05.
FIGURE 5 | Conditioned place avoidance. (A) Scheme depicting the 
behavioral training and treatment groups used in the conditioned place 
avoidance (CPA) procedure. Although for clarity the scheme presents the 
“holes” fl oor as CS+, this factor was counterbalanced across genotypes and 
dox treatment (see Section “Materials and Methods” for further details). 
(B) CPA was evaluated as the percent of time spent in the environment paired 
to morphine withdrawal during a preference test conducted 24 h after the last 
conditioning session but, for clarity, those data were arithmetically 
transformed (CPA = % time spent in CS+ minus 100%). The black and white 
bars depict the results for ACREB-St and littermate control mice, respectively. 
The horizontal dotted line indicates the indifference (e.g., 50%) point. 
*p < 0.05 as compared to all other groups.
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F
1,30
 = 4.43, p < 0.05, respectively) as well as its interaction yielded 
a signifi cant effect (F
1,30
 = 5.07, p < 0.05). Thus, as it can be seen 
in Figure 5B, ACREB-St mice off dox (transgene on) spent less 
time than their control littermates in the environment associated 
to morphine withdrawal. Again, post hoc comparisons revealed that 
dox-untreated ACREB-St mice exhibit a higher degree of CPA than 
the other three groups (p < 0.05 in all cases), demonstrating that 
CREB inhibition enhanced the avoidance behavior associated to 
withdrawal in a reversible manner.
DISCUSSION
In the present study we introduce a new strain of bitransgenic mice, 
ACREB-St, expressing the repressor of the CREB family of tran-
scription factors A-CREB in striatal neurons in a regulatable man-
ner. ACREB-St mice did not show any gross anatomical alteration or 
apparent neurodegeneration. These results suggest that this strain 
of mice might be a more suitable tool to study the role of CREB 
in striatal neurons than some previous genetic models that lacked 
striatal-specifi city (Maldonado et al., 1996; Valverde et al., 2004) or 
presented some major physiological and morphological alterations, 
such as striatal degeneration (Mantamadiotis et al., 2002). The use 
of genetically modifi ed mice might also provide some advantages 
over viral-mediated delivery, such as being a less intrusive proce-
dure (Carlezon et al., 1998; Barrot et al., 2002), although this may 
be achieved at the prize of a lower anatomical resolution.
ACREB-St mice exhibited a dox-reversible enhancement of 
CPP after repeated morphine administration. This observation is 
in agreement with previous studies concluding that an increase of 
CREB activity in the NA results in a decrease of drug-induced CPP, 
whereas the blockade of CREB function through expression of a 
dominant-negative protein had the opposite effect (Carlezon et al., 
1998; Barrot et al., 2002; McClung and Nestler, 2003). However, 
the role of CREB in the striatum does not seem to be restricted 
to appetitive contingencies. Despite showing normal withdrawal, 
ACREB-St also displayed a dox-reversible enhancement of condi-
tioned avoidance to a context paired to morphine withdrawal. This 
observation is in agreement with previous studies showing that 
viral-mediated overexpression of mCREB (another dominant nega-
tive CREB mutant) in the shell of the NA increased CPA induced 
by high doses of naloxone in morphine-naïve rats, whereas CREB 
overexpression resulted in the opposite effect (Barrot et al., 2002). 
Studies involving the overexpression of the natural CREB repres-
sor ICER in striatal areas like the NA also resulted in enhanced 
responses toward both appetitive and aversive stimuli (Green et al., 
2006). Thus, CREB-related neuroplasticity in some striatal regions 
seems to dampen behavioral responses to emotionally relevant 
stimuli regardless its appetitive or aversive value.
Previous studies using CREB defi cient mice have reported a 
decrease of the intensity of morphine withdrawal (Maldonado 
et al., 1996; Valverde et al., 2004), this fi nding was not reproduced 
in ACREB-St mice, but such a result was not unexpected because 
the implication of CREB in the somatic and physiological signs 
of morphine withdrawal has been directly related to the activity 
of this transcription factor in the locus coeruleus and not to its 
action in striatal structures (Valverde et al., 2004; Han et al., 2006). 
Conversely, the fact that the expression of this transcription factor in 
the striatum substantially contributes to the magnitude of approach/
avoidance responses toward CS seems in agreement with the role 
of this anatomical structure in the regulation of  several cognitive 
and motor functions (Everitt and Robbins, 2005). Our fi ndings and 
those of some previous studies (Carlezon et al., 1998; Barrot et al., 
2002; McClung and Nestler, 2003; Green et al., 2006) could be inter-
preted as the result of inhibiting CREB activity at the NA. In this 
regard, it is known that a reduction of CREB activity in GABAergic 
neurons of the NA decreases their excitability (Dong et al., 2006). 
The reduction in the fi ring of GABAergic neurons would result in 
decreased GABA and dynorphin- mediated inhibition over VTA-
dopaminergic neurons (Carlezon et al., 2005) and this reduction 
of the inhibitory input would, in turn, lead to an increased prob-
ability of fi ring of dopaminergic VTA neurons as well as increased 
dopamine release and dopamine-receptor binding at the level of 
the NA. Interestingly, both a reduction in the number of accumbal 
fi ring neurons (German and Fields, 2007) as well as in the magni-
tude of the dopaminergic input to the NA core have been directly 
related to the acquisition and consolidation of Pavlovian approach 
responses (Parkinson et al., 1999; Di Ciano et al., 2001; Everitt and 
Robbins, 2005). However, since the reduction on CREB-related gene 
expression in ACREB-St mice extends to striatal areas other than the 
NA (i.e., dorsal striatum, Figures 1 and 2), alternative explanations 
could also be considered to explain the mechanisms underlying the 
effects on behavior presented here (see Fasano et al., 2009). Thus, 
disinhibition of striatal GABAergic interneurons does not only lead 
to a disinhibition of the VTA dopaminergic neurons projecting to 
the NA, but also to those connecting the substantia nigral and dor-
sal regions of the striatum. Several regions of the striatum might 
mediate behavioral processes relevant for the observed phenotypes 
(Kelley, 2004; Everitt and Robbins, 2005).
In summary, the results of the present study suggest that CREB-
related neuroplasticity in the striatum might be implicated in the 
promotion of appropriate avoidance or approach responses toward 
environmental stimuli associated to emotionally relevant stimuli. The 
exact mechanisms underlying this process are unclear, but coupled to 
data from previous studies, our results indicate that those behavioral 
fi ndings might arise from the ability of CREB-mediated neuroplastic-
ity to alter dopamine-related mechanisms at the NA and/or dorsal 
striatum regions. Further, as our results differ from those obtained 
when using anatomically unspecifi c CREB defi cient mice (Valverde 
et al., 2004; Bilbao et al., 2008), but are coincident with those promot-
ing a selective reduction of CREB-related activity in the NA (Carlezon 
et al., 1998; Barrot et al., 2002; McClung and Nestler, 2003; Green 
et al., 2006), the present study emphasizes the importance of using 
experimental complementary approaches suitable to dissect the mul-
tiple actions of CREB in different brain regions.
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